HONG KONG – Researchers here have shown for the first time that during bone formation and growth, cartilage cells or chondrocytes survive and develop into mature osteoblasts, the cells that form new bone, contradicting the long-held tenet that chondrocytes and osteoblasts are separate independently developing cell types.

HONG KONG – A multidisciplinary research team from Singapore has made a significant breakthrough in the understanding of the molecular basis of benign fibroadenomas, one of the most common breast tumors in women, which could have important implications for the diagnosis and treatment of malignant breast cancers.

HONG KONG – A multidisciplinary research team from Singapore has made a significant breakthrough in the understanding of the molecular basis of benign fibroadenomas, one of the most common breast tumors in women, which could have important implications for the diagnosis and treatment of malignant breast cancers.

HONG KONG — Defects in fatty acid-binding proteins (FABPs) may help to explain the pathology in some cases of schizophrenia and autism spectrum disorders (ASDs), possibly leading to the development of tailor-made therapies for those mental disorders, Japanese neuroscientists reported.

HONG KONG — Defects in fatty acid-binding proteins (FABPs) may help to explain the pathology in some cases of schizophrenia and autism spectrum disorders (ASDs), possibly leading to the development of tailor-made therapies for those mental disorders, Japanese neuroscientists reported.

HONG KONG — Researchers here have elucidated a previously unknown signaling pathway involved in mediating the synaptic dysfunctions associated with Alzheimer's disease (AD) and have identified a promising new small-molecule disease-modifying intervention that may delay progress of the disease.

HONG KONG — Researchers here have elucidated a previously unknown signaling pathway involved in mediating the synaptic dysfunctions associated with Alzheimer's disease (AD) and have identified a promising new small-molecule disease-modifying intervention that may delay progress of the disease.

HONG KONG – Researchers from the Riken Center for Life Science Technologies in Japan said they have gained new insights into the role of a chemokine protein in the enhancement of stem cell pluripotency, an improved understanding that could lead to the development of more stable and clinically useful stem cells.

HONG KONG – Researchers from the Riken Center for Life Science Technologies in Japan said they have gained new insights into the role of a chemokine protein in the enhancement of stem cell pluripotency, an improved understanding that could lead to the development of more stable and clinically useful stem cells.